|
RICHMOND, VA – January 15, 2019 – The Virginia Biosciences Health Research Corporation (VBHRC), now known as Virginia Catalyst, today announced that it is hosting a luncheon, in conjunction with Virginia Bio and CIT, featuring the National Institute on Drug Abuse (NIDA), Small Business Innovation Research (SBIR) program, and Deloitte Consulting. As part of the event, scheduled for January 23 from 11:30am-1:00pm, NIDA's Victor Prikhodko, Business Advisor to the Office of Translational Initiatives and Program Innovations (OTIPI), will discuss NIDA SBIR’s funding opportunities, including the recently released “HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis” RFA, and present some best practices for strong applications. In addition, Jon Baba, a Principal in Deloitte’s Global Public Sector Practice, will discuss Deloitte’s findings and strategic recommendations for neuroscience and addiction in the Commonwealth of Virginia. The Virginia Catalyst recently engaged Deloitte Consulting to explore and validate Virginia’s unmet addiction needs and benchmark Virginia’s competitive strengths and resources, and this presentation will unveil those findings.
Read the full press release here CLICK HERE to register for this free event CLICK HERE to view this event as it is live streamed (this event will not be recorded) In addition to these presentations on January 23rd: the Virginia Catalyst is providing a unique opportunity to have a 1:1 meeting with Victor Prikhodko from NIDA! Mr. Prikhodko will be available for 30-minute one-on-one meetings to discuss NIDA’s SBIR funding opportunities and to provide your company specific advice on best practices for strong applications and how to enhance your opportunity to receive funding. Meetings are scheduled on a first-come, first-serve basis! To schedule a 1:1 meeting contact: Suzänne Taylor staylor@VirginiaCatalyst.org 804.937.3919
0 Comments
|
RSS Feed
